Home Clinical Topics FDA grants waiver for flu test

FDA grants waiver for flu test

On January 6, the U.S. Food and Drug Administration (FDA) granted the first waiver to allow a nucleic acid-based test, the Alere i Influenza A & B test, to be used in a greater variety of healthcare settings. The test uses a nasal swab sample from a patient and provides results in as little as 15 minutes. Negative results don’t rule out influenza virus infection. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here